Sulfur hexafluoride lipid-type a microspheres
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
55 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Abdominal injuries | D000007 | — | — | 2 | 2 | — | 3 | — | 5 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 1 | — | 1 | 1 | 4 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | — | 3 | — | 4 |
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | 1 | 1 | 3 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | 1 | 1 | 3 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 2 | — | 1 | — | 3 |
| Crohn disease | D003424 | EFO_0000384 | K50 | — | — | — | 1 | 1 | 2 |
| Hydrocephalus | D006849 | HP_0000238 | G91 | — | 1 | — | 1 | — | 2 |
| Syndrome | D013577 | — | — | — | — | — | 1 | — | 1 |
| Hepatic veno-occlusive disease | D006504 | — | K76.5 | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 1 | 2 | — | — | 3 |
| Coronary disease | D003327 | — | — | — | — | 2 | — | — | 2 |
| Coronary artery disease | D003324 | — | I25.1 | — | — | 2 | — | — | 2 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 2 | — | — | 2 |
| Covid-19 | D000086382 | — | — | — | — | 1 | — | — | 1 |
| Ischemia | D007511 | EFO_0000556 | — | — | — | 1 | — | — | 1 |
| Hypoxia | D000860 | HP_0012418 | R09.02 | — | — | 1 | — | — | 1 |
| Brain diseases | D001927 | HP_0001298 | G93.40 | — | — | 1 | — | — | 1 |
| Brain ischemia | D002545 | EFO_0003883 | I67.82 | — | — | 1 | — | — | 1 |
| Brain hypoxia-ischemia | D020925 | EFO_1000846 | P91.6 | — | — | 1 | — | — | 1 |
Show 2 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | — | 2 | — | — | — | 2 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 2 | — | — | — | 2 |
| Appendicitis | D001064 | EFO_0007149 | K37 | 1 | 1 | — | — | — | 2 |
| Vesico-ureteral reflux | D014718 | EFO_0007536 | N13.7 | 1 | 1 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 2 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | 1 | — | — | — | 1 |
| Chronic renal insufficiency | D051436 | — | N18 | — | 1 | — | — | — | 1 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | 1 | — | — | — | 1 |
| Von hippel-lindau disease | D006623 | — | Q85.83 | — | 1 | — | — | — | 1 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | 1 | — | — | — | 1 |
Show 14 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stroke | D020521 | EFO_0000712 | I63.9 | 1 | — | — | — | 1 | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | — | — | — | — | 2 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | — | — | — | — | 1 |
| Fibrosis | D005355 | — | — | 1 | — | — | — | — | 1 |
| Kidney transplantation | D016030 | — | — | 1 | — | — | — | — | 1 |
| Breast diseases | D001941 | — | N60-N65 | 1 | — | — | — | — | 1 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | 1 | — | — | — | — | 1 |
| Fibromuscular dysplasia | D005352 | EFO_1000938 | I77.3 | 1 | — | — | — | — | 1 |
| Congenital hip dislocation | D006618 | HP_0001385 | — | 1 | — | — | — | — | 1 |
| Developmental dysplasia of the hip | D000082602 | — | — | 1 | — | — | — | — | 1 |
Show 5 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Adenocarcinoma | D000230 | — | — | — | — | — | — | 2 | 2 |
| Pancreatic ductal carcinoma | D021441 | — | — | — | — | — | — | 1 | 1 |
| Stress echocardiography | D025401 | — | — | — | — | — | — | 1 | 1 |
| Hematoma | D006406 | EFO_0010680 | — | — | — | — | — | 1 | 1 |
| Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | — | — | — | 1 | 1 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 1 | 1 |
| Dentin dysplasia | D003805 | — | K00.5 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use